Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion
- 31 May 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 19 (6) , 1123-1128
- https://doi.org/10.1016/0735-1097(92)90312-b
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)Journal of the American College of Cardiology, 1992
- In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparinThe Lancet, 1990
- A prospective, randomized trial comparing combination half dose tPA with streptokinase to full dose tPA in acute myocardial infarction: Preliminary reportJournal of the American College of Cardiology, 1990
- Physicians' Conflicts of InterestNew England Journal of Medicine, 1989
- Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1989
- Relations between members of the British Cardiac Society and industryHeart, 1989
- A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: A pilot studyJournal of the American College of Cardiology, 1989
- Conflict-of-Interest Guidelines for a Multicenter Clinical Trial of Treatment after Coronary-Artery Bypass-Graft SurgeryNew England Journal of Medicine, 1989
- Ethical Imperialism?New England Journal of Medicine, 1988
- ROLE OF THE PHARMACEUTICAL INDUSTRY IN MAJOR CLINICAL TRIALSThe Lancet, 1987